Skip to main content
. Author manuscript; available in PMC: 2021 Aug 23.
Published in final edited form as: Clin Cancer Res. 2019 Aug 22;25(23):6939–6947. doi: 10.1158/1078-0432.CCR-19-1026

Figure 2.

Figure 2

Planar whole-body scans of four patients with metastatic NETs after injection of 177Lu-satoreotide tetraxetan at the indicated times. Intense tracer uptake was observed in liver, lymph node, and osseous metastases.